PARSHALL B LYNNE — SEC Form 4 filings
SEC reporting owner CIK 1073385. 27 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2024-05-16 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 17 filings — 100,000 shares, $5,931,370 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 10,750 shares @ $50.42 ($542,015) in IONIS PHARMACEUTICALS INC, filed 2025-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CYTOKINETICS INC (CYTK) | Director | 15 | — | 12 legs · 60,000 sh · $3,549,750 | 22 |
| IONIS PHARMACEUTICALS INC (IONS) | Director | 9 | — | 8 legs · 40,000 sh · $2,381,620 | 8 |
| Foghorn Therapeutics Inc. (FHTX) | Director | 3 | — | — | 3 |
Form 4 filings — PARSHALL B LYNNE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $71.48 | EDGAR |
| 2026-06-25 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 28,000 (derivative) @ $4.08 | EDGAR |
| 2026-06-01 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $74.08 | EDGAR |
| 2026-05-27 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 4,466 @ $76.19 · Sale (S): 534 @ $76.97 | EDGAR |
| 2026-03-02 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $61.21 | EDGAR |
| 2026-02-13 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 5,000 @ $82.72 | EDGAR |
| 2025-11-19 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $64.73 | EDGAR |
| 2025-10-16 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 5,000 @ $71.74 | EDGAR |
| 2025-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,750 @ $50.42 · Sale (S): 9,250 @ $51.49 | EDGAR |
| 2025-08-08 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 4,600 @ $41.87 · Sale (S): 400 @ $42.63 | EDGAR |
| 2025-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 25,000 (derivative) @ $4.79 | EDGAR |
| 2025-05-15 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0 | EDGAR |
| 2024-09-09 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $54.92 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $57.26 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $55.20 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $59.84 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,677 @ $0 · Option exercise (M): 4,677 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $55.82 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,111 (derivative) @ $0 · Grant/award (A): 4,079 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $54.22 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $5.52 | EDGAR |
| 2024-06-17 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $52.55 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $48.64 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,600 @ $0 · Grant/award (A): 3,636 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1073385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →